Treatments and Rescue Therapies for Methotrexate Toxicity
At a Glance
Methotrexate toxicity is treated urgently with rescue therapies like leucovorin to protect healthy cells, and sometimes glucarpidase to rapidly break down the drug. Hospitals also use aggressive IV hydration and sodium bicarbonate to flush the medication out and prevent severe kidney damage.
When methotrexate (MTX) levels reach a toxic range, medical teams must act quickly to neutralize the drug and protect your organs. Treatment focuses on two main goals: bypassing the “block” MTX creates in your cells and flushing the drug out of your kidneys as fast as possible.
The Standard Rescue: Leucovorin
Leucovorin (also called folinic acid) is the cornerstone of methotrexate rescue [1].
- How it Works: Methotrexate works by blocking an enzyme (DHFR) that creates the active folate your cells need to survive. Leucovorin is a “reduced folate”—it is already in the active form your body needs [2].
- The Bypassing Effect: By providing these active folates, leucovorin does an “end-run” around the methotrexate block, allowing your healthy cells to continue making DNA and repairing themselves even while methotrexate is present [3][4].
- Timing is Key: In high-dose MTX therapy, leucovorin rescue typically begins 24 to 36 hours after the start of the methotrexate infusion [5]. At the 42-to-48-hour mark, doctors check the blood levels of methotrexate to adjust the leucovorin dose, ensuring you receive enough rescue medication until the MTX is safely cleared [4].
The Emergency Antidote: Glucarpidase (Voraxaze)
For severe toxicity, especially when the kidneys are failing, doctors may use an “antidote” called glucarpidase [6].
- Indications: It is typically reserved for patients with very high levels of methotrexate who also have acute kidney injury (AKI) [4].
- Rapid Action: Glucarpidase is an enzyme that literally chops methotrexate molecules into smaller, non-toxic pieces. It can reduce the amount of methotrexate in your blood by over 95% within just 15 minutes [4].
- The 60-Hour Window: For the best results, it should ideally be administered within 48 to 60 hours of the start of the methotrexate infusion [4][7].
- Testing Warning: After receiving glucarpidase, standard lab tests for methotrexate may give “false high” readings for several days. Special testing methods (like HPLC) are needed to get an accurate measurement [8][9].
Supportive Care: Flushing the System
In the hospital, several steps are taken to prevent the drug from damaging the kidneys further.
Aggressive Hydration
You will receive large amounts of intravenous (IV) fluids—often 3 liters or more per day [10]. This “washes” the kidneys and prevents methotrexate from concentrating and forming crystals [4].
Urinary Alkalinization
Methotrexate is much more soluble (dissolvable) in alkaline (basic) urine than in acidic urine.
- Sodium Bicarbonate: Doctors use IV sodium bicarbonate to keep your urine pH at 7.0 or higher [4].
- Why it Matters: Raising the urine pH from 6 to 7 can increase the solubility of methotrexate by 10 times, making it much easier for your kidneys to flush it out without getting damaged [4].
Salvage Therapy: Hemodialysis
If glucarpidase is not available or if the toxicity is life-threatening, doctors may use hemodialysis or Continuous Renal Replacement Therapy (CRRT) [11][12].
- The “Rebound” Effect: While dialysis is effective at removing methotrexate from the blood, levels often “rebound” (go back up) a few hours after the session ends because methotrexate “hides” in your body tissues and slowly leaks back into the bloodstream [12][4]. Multiple sessions may be required.
What to Expect During Recovery
If you have experienced methotrexate toxicity, your body needs time to rebuild the healthy cells that were damaged.
- Mouth Sores (Mucositis): Typically begin to heal within 7 to 14 days after the methotrexate is cleared from your system and leucovorin rescue is provided.
- Blood Counts (Pancytopenia): Your white blood cells and platelets will usually reach their lowest point (the “nadir”) between 7 and 14 days, and then slowly recover over the following 2 to 3 weeks. You may need blood transfusions or growth factors to support this recovery.
- Kidney Function: Acute kidney injury often resolves with aggressive hydration and clearance of the drug, but it can take weeks for creatinine levels to return to baseline.
Common questions in this guide
How does leucovorin help with methotrexate toxicity?
When is glucarpidase used for methotrexate toxicity?
Why do I need IV fluids if my methotrexate levels are high?
How long does it take to recover from methotrexate toxicity?
Why do they monitor and change my urine pH during treatment?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the exact target urine pH we are aiming for, and how often will it be tested?
- 2.If we use glucarpidase, how will we accurately monitor my methotrexate levels afterward, given that standard tests may be unreliable?
- 3.How much leucovorin will I receive, and for how many days will the 'rescue' continue?
- 4.At what point do we consider the methotrexate fully cleared from my system?
- 5.Once I am fully recovered from this toxicity event, is it ever safe for me to restart methotrexate, or do we need a new treatment plan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Accidental methotrexate overdose leading to multisystem toxicity: A case report.
Asaduzzaman M, Karim MR, Saha P, et al.
Toxicology reports 2024; (13()):101821 doi:10.1016/j.toxrep.2024.101821.
PMID: 39640903 - 2
Navigating methotrexate toxicity: Examining the therapeutic roles of folinic acid and glucarpidase.
Chan BS, Bosco AA, Buckley NA
British journal of clinical pharmacology 2025; (91(3)):628-635 doi:10.1111/bcp.16096.
PMID: 38889902 - 3
Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia.
Oosterom N, de Jonge R, Smith DEC, et al.
PloS one 2019; (14(9)):e0221591 doi:10.1371/journal.pone.0221591.
PMID: 31527879 - 4
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
Ramsey LB, Balis FM, O'Brien MM, et al.
The oncologist 2018; (23(1)):52-61 doi:10.1634/theoncologist.2017-0243.
PMID: 29079637 - 5
Serum Methotrexate Level Predicts Acute Kidney Injury After High-Dose Methotrexate: A Case Report and Single-Center Experience.
Yen PW, Lin HY, Wu CC, et al.
International journal of nephrology and renovascular disease 2024; (17()):277-285 doi:10.2147/IJNRD.S487368.
PMID: 39525565 - 6
Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials.
Meyers PA
Pediatric blood & cancer 2023; (70(11)):e30617 doi:10.1002/pbc.30617.
PMID: 37553477 - 7
Consensus on managing delayed methotrexate elimination in high-dose therapy: insights from the Middle East.
Al Manasour M, Absi A, Alhuraiji A, et al.
Frontiers in oncology 2025; (15()):1660937 doi:10.3389/fonc.2025.1660937.
PMID: 41278262 - 8
Analytical Validation of a Second-Generation Methotrexate Immunoassay.
Wilson R, Yamaguchi D, Garrett J, et al.
The journal of applied laboratory medicine 2026; (11(1)):73-82 doi:10.1093/jalm/jfaf166.
PMID: 41146625 - 9
DAMPAned Methotrexate: A Case Report and Review of the Management of Acute Methotrexate Toxicity.
Young A, Beriault D, Jung B, et al.
Canadian journal of kidney health and disease 2019; (6()):2054358119895078 doi:10.1177/2054358119895078.
PMID: 31903191 - 10
The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients.
Traivaree C, Likasitthananon N, Monsereenusorn C, Rujkijyanont P
Cancer management and research 2018; (10()):4471-4478 doi:10.2147/CMAR.S172117.
PMID: 30349379 - 11
Severe Methotrexate toxicity after ectopic pregnancy: a case report managed with continuous renal replacement therapy.
Chao Y, Liu Q, Li A, Zhang Y
Cancer chemotherapy and pharmacology 2026; (96(1)).
PMID: 42301427 - 12
High-flux hemodialysis as rescue therapy for high-dose methotrexate toxicity: case series and clinical insights.
Tome ACN, Santos KF, Lima EQ, Ramalho RJ
Frontiers in medicine 2025; (12()):1495705 doi:10.3389/fmed.2025.1495705.
PMID: 40160322
This page explains medical treatments for methotrexate toxicity for educational purposes only. It does not replace professional medical advice. Always consult your healthcare team for emergency treatment, monitoring, and recovery care.
Get notified when new evidence is published on Methotrexate toxicity.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.